sodium citrate
Approved
Oct 3, 1980
Trisodium citrate is a chemical compound with the molecular formula Na3C6H5O7. It is sometimes referred to simply as "sodium citrate", though sodium citrate can refer to any of the three sodium salts of citric acid. It possesses a saline, mildly tart taste, and is a mild base. — Wikipedia
Clinical trial activity
41 trials · 51 clinical orgs · 5 marketing orgs
Earliest trial started Mar 1, 2003 (NCT00286273)
Timeline
1980s
2000s
- Jan 1, 2006
Earliest Phase 3 Sponsor(trial)
- Sep 27, 2006
Akorn, Inc. — Marketing Organization
- Sep 27, 2006
Epic Pharma Llc — Marketing Organization
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
2010s
- Feb 3, 2010
B. Braun — Marketing Organization
Indications
Approved for
Studied for
- Acute Kidney Injury · Phase 4
- Air Travel · Phase 2/Phase 3
- Anosmia · Phase 2
- Anticoagulants · Phase 4
- Arthritis · Phase 1
- Bacteremia · Phase 4
- Blood Component Removal · Phase 4
- Cataract · Phase 2
- Catheter-Related Infections · Phase 4
- Corneal Diseases · Phase 4
- Coronavirus Infections · Phase 1/Phase 2
- COVID-19 · Phase 2
- Diabetes Mellitus, Type 1 · Phase 1
- Dry Eye Syndromes · Phase 3
- Enhanced Recovery After Surgery · Phase 1/Phase 2
- Healthy Volunteers · Phase 1
- Heart Defects, Congenital · Early Phase 1
- Infections · Phase 4
- Iron Deficiencies · Phase 2
- Kidney Calculi · Phase 4
- Kidney Failure, Chronic · Phase 4
- Liver Failure · Phase 2/Phase 3
- Olfaction Disorders · Phase 2
- Pharmacokinetics · Phase 1
- Polycystic Kidney, Autosomal Dominant · Phase 2
- Propionic Acidemia · Phase 1
- Renal Dialysis · Phase 2/Phase 3
- Renal Insufficiency, Chronic · Phase 4
- Respiratory Insufficiency · Early Phase 1
- Upper Extremity Deep Vein Thrombosis · Phase 2/Phase 3
- Uveitis, Anterior · Phase 3
Mechanism of action
- ElectrolyteSupplementation
Electrolyte supplementation
Combination products
isolyte e
with potassium chloride, sodium acetate, sodium chloride, calcium chloride, magnesium
Also known as balanced salt, bss
isolyte e w/ dextrose
with potassium chloride, sodium acetate, sodium chloride, calcium chloride, glucose monohydrate, magnesium
Also known as isolyte e in dextrose
Approval history
- approvedOct 3, 1980
- approvedOct 3, 1980
Chemistry & pharmacology
SMILES
O=P([O-])([O-])O.[K+].[K+]- Mol. weight
- 174.17 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaTrisodium citrate ↗
- ChEMBLCHEMBL1355 ↗
- ChEMBLCHEMBL1200459 ↗
- WikipediaSodium citrate ↗
- WikipediaDisodium citrate ↗
Also known as
- alka seltzer
- alka seltzer
- anhydrous sodium citrate
- anticoagulant sodium citrate
- canesten oasis
- citra ph
- cymalon
- cymalon
- cystemme
- cystocalm
- cystoleve
- disodium citrate
- disodium citrate
- e331
- e331
- hydrous sodium citrate
- isolyte
- isolyte
- isolyte e
- micolette
- micralax
- potassium-sodium citrate
- relaxit
- sod cit
- sodium citrate
- sodium citrate
- sodium citrate
- sodium citrate
- sodium citrate
- sodium citrate
- sodium citrate
- sodium citrate
- sodium citrate anhydrous
- sodium citrate anhydrous
- sodium citrate, anhydrous
- sodium citrate, anhydrous
- sodium citrate, anhydrous
- sodium citrate dihydrate
- sodium citrate dihydrate
- trisodium citrate
- trisodium citrate
- trisodium citrate
- trisodium citrate anhydrous
- trisodium citrate anhydrous
- trisodium citrate, anhydrous
- trisodium citrate, anhydrous
- trisodium citrate dihydrate
- trisodium citrate dihydrate
- trisodium citrate dihydrate
- urisal
- urisal
- zuragen
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06994312 | N/A | Jul 1, 2025 | Jinlin University |
| NCT06538584 | Phase 1/Phase 2 (Phase 2) | Sep 9, 2024 | University of Chicago |
| NCT06204432 | Phase 2 | Dec 1, 2023 | University of North Carolina at Chapel Hill |
| NCT05188339 | Phase 2/Phase 3 (Phase 3) | Jul 20, 2022 | Chang Gung University |
| NCT04756427 | Phase 4 | Jan 31, 2022 | Johns Hopkins University |
| NCT05191290 | Phase 4 | Jan 21, 2022 | University of Ljubljana |
| NCT05154968 | Phase 1 | Nov 1, 2021 | Eli Lilly |
| NCT05067270 | Phase 1 | Oct 22, 2021 | Eli Lilly |
| NCT04802785 | Phase 2/Phase 3 (Phase 3) | Jun 30, 2021 | lurye Clinic |
| NCT04792424 | N/A | Apr 1, 2021 | Chulalongkorn University |
| NCT04447781 | Phase 1/Phase 2 (Phase 2) | Jul 15, 2020 | Coalition for Epidemic Preparedness Innovations, Inovio Pharmaceuticals, International Vaccine Institute, Seoul National University |
| NCT04139525 | N/A | Nov 1, 2019 | University of Ljubljana |
| NCT04284657 | Phase 2 | Jan 30, 2019 | University of Southern California |
| NCT03791190 | N/A | Sep 6, 2018 | People's Liberation Army of China |
| NCT06646328 | Phase 4 | Jun 9, 2018 | Hospital General Universitario de Castellón, Hospital Universitario de La Plana, University of Valencia |
| NCT03683563 | N/A | Apr 11, 2018 | University of Ljubljana |
| NCT03419923 | N/A | Oct 1, 2017 | Shantou University |
| NCT03281928 | N/A | Oct 1, 2017 | University of Chicago |
| NCT02905981 | Phase 2 | Oct 1, 2016 | Rockwell Medical Inc |
| NCT02767128 | Phase 1 | Apr 1, 2016 | Rockwell Medical Inc |
Organizations
Research & Development (51)
Marketing (7)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Akorn, Inc. | For profit | MKTG | Sep 27, 2006 |
| Alcon | For profit | NDA2 | Dec 10, 1997 |
| B. Braun | For profit | NDA2 | Oct 3, 1980 |
| B. Braun | For profit | MKTG | Feb 3, 2010 |
| B. Braun | For profit | NDA | Oct 3, 1980 |
| Epic Pharma Llc | For profit | MKTG | Sep 27, 2006 |
| Nestle | For profit | NDA2 | Dec 10, 1997 |